1
Total Mentions
1
Documents
0
Connected Entities
HOUSE_OVERSIGHT_024003 - HOUSE_OVERSIGHT_024116
have included Array Pharmaceuticals (NLV-II, NASDAQ: ARRY; led a structured follow-on investment, NLV team member joined the board, exited at 2.25x), Acadia Pharmaceuticals (NLV-II, NASDAQ: ACAD, exited at 2.5x) and _ Intercept Pharmaceuticals (NLV-II, NASDAQ: ICPT; anchored company’s IPO, NLV team member
Page: HOUSE_OVERSIGHT_024046 →No connected entities